Reviewing Nutex Health (NASDAQ:NUTX) & bioMerieux (OTCMKTS:BMXMF)

Nutex Health (NASDAQ:NUTX) and bioMerieux (OTCMKTS:BMXMF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

Profitability

This table compares Nutex Health and bioMerieux’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	11.62%	37.44%	14.16%
bioMerieux	N/A	N/A	N/A

Earnings and Valuation

This table compares Nutex Health and bioMerieux”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$479.95 million	2.47	$52.10 million	$18.49	9.07
bioMerieux	$4.31 billion	3.55	$467.68 million	N/A	N/A

bioMerieux has higher revenue and earnings than Nutex Health.

Insider and Institutional Ownership

5.3% of Nutex Health shares are owned by institutional investors. 36.9% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and price targets for Nutex Health and bioMerieux, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	1	2	0	2.67
bioMerieux	0	1	0	0	2.00

Nutex Health presently has a consensus target price of $252.50, indicating a potential upside of 50.62%. Given Nutex Health’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Nutex Health is more favorable than bioMerieux.

Volatility and Risk

Nutex Health has a beta of -0.08, indicating that its share price is 108% less volatile than the S&P 500. Comparatively, bioMerieux has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500.

Summary

Nutex Health beats bioMerieux on 8 of the 12 factors compared between the two stocks.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About bioMerieux

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.